Pharmacytimes http://www.pharmacytimes.com/rss PharmacyTimes.com offers continuing education (CE) courses, career guidance for pharmacy students, online-only articles, digital versions of the print issue, and more, that are essential to pharmacists en-us Thu, 27 Jul 17 04:48:40 +0000 Thu, 27 Jul 17 04:48:40 +0000 5 Ways Sharks Can Advance Human Medicine http://www.pharmacytimes.com/news/5-ways-sharks-can-advance-human-medicine http://www.pharmacytimes.com/news/5-ways-sharks-can-advance-human-medicine Sink your teeth into these 5 ways that sharks could benefit humans, potentially leading to new drug developments. Tue, 25 Jul 17 13:46:00 +0000 Biologic Insulin Gets FDA Tentative Approval http://www.pharmacytimes.com/product-news/biologic-insulin-gets-fda-tentative-approval http://www.pharmacytimes.com/product-news/biologic-insulin-gets-fda-tentative-approval The FDA has granted tentative approval to Merck&#39;s Lusduna Nexvue (insulin glargine injection) 100 units/mL. The drug is a follow-on biologic basal insulin for patients with type 2 diabetes and is administered through a pre-filled dosing device, according to a press release.&nbsp; Mon, 24 Jul 17 14:22:00 +0000 Generic Drugs Trend Upward in Workers Compensation http://www.pharmacytimes.com/news/generic-drugs-trend-upward-in-workers-compensation http://www.pharmacytimes.com/news/generic-drugs-trend-upward-in-workers-compensation Generic drug prescribing and use continues to trend upward in workers compensation, according to a report recently released by Coventry Workers Comp Services. Generic drug prescribing and use continues to trend upward in workers compensation, according to a report recently released by Coventry Workers Comp Services. &nbsp; Mon, 24 Jul 17 13:06:00 +0000 Self-Injectable for SLE Gets FDA Nod http://www.pharmacytimes.com/news/selfinjectable-for-sle-gets-fda-nod http://www.pharmacytimes.com/news/selfinjectable-for-sle-gets-fda-nod Officials with GSK announced that the US FDA has approved a new subcutaneous formulation of belimumab (Benlysta) for the treatment of adult patients with active, autoantibody?positive systemic lupus erythematosus (SLE) who are receiving standard therapy. Fri, 21 Jul 17 18:51:00 +0000 More Than 400 Charged in National Health Care Fraud http://www.pharmacytimes.com/news/more-than-400-charged-in-national-health-care-fraud http://www.pharmacytimes.com/news/more-than-400-charged-in-national-health-care-fraud In what is being called the &ldquo;largest health care fraud enforcement action in Department of Justice history,&rdquo; 412 individuals, including 115 health care providers, across 41 federal districts have been charged for their involvement in health care fraud and opioid distribution schemes.&nbsp; Fri, 14 Jul 17 15:57:49 +0000 4 New FDA Approvals to Know from June 2017 http://www.pharmacytimes.com/news/4-new-fda-approvals-to-know-from-june-2017 http://www.pharmacytimes.com/news/4-new-fda-approvals-to-know-from-june-2017 Learn about the new products and expanded indications approved by the FDA in June 2017. Fri, 14 Jul 17 15:20:31 +0000 Digital Health Platform Engages Patients at Home http://www.pharmacytimes.com/product-news/digital-health-platform-engages-patients-at-home- http://www.pharmacytimes.com/product-news/digital-health-platform-engages-patients-at-home- An&nbsp;FDA-registered health hub, the platform shows promising early results, including driving patient engagement rates as high as 80%, leading to changes in underlying behaviors affecting medication nonadherence. Wed, 12 Jul 17 14:14:54 +0000 Home-based Medication Errors Rose Between 2000 and 2012 http://www.pharmacytimes.com/news/homebased-medication-errors-rose-between-2000-and-2012 http://www.pharmacytimes.com/news/homebased-medication-errors-rose-between-2000-and-2012 Home-based medication errors are becoming more common, according to a report from The Center for Injury Research and Policy and the Central Ohio Poison Center at Nationwide Children&rsquo;s Hospital and &nbsp;published a study in <em>Clinical Toxicology</em> Wed, 12 Jul 17 14:00:00 +0000 Sanofi Officials Announce Plans to Purchase Protein Sciences http://www.pharmacytimes.com/news/sanofi-officials-announce-plans-to-purchase-protein-sciences http://www.pharmacytimes.com/news/sanofi-officials-announce-plans-to-purchase-protein-sciences Protein Sciences received approval from the US FDA&nbsp;in October 2016 for their Flublok&nbsp;Quadrivalent Influenza Vaccine. Tue, 11 Jul 17 19:58:45 +0000 Drinking Coffee Lowers Mortality Risk? http://www.pharmacytimes.com/news/drinking-coffee-lowers-mortality-risk http://www.pharmacytimes.com/news/drinking-coffee-lowers-mortality-risk A recently-published study has found another reason to enjoy a cup of coffee.&nbsp; Tue, 11 Jul 17 13:00:00 +0000 WHO Warns of Increasing Antibiotic-Resistant Gonorrhea http://www.pharmacytimes.com/news/who-warns-of-increasing-antibioticresistant-gonorrhea http://www.pharmacytimes.com/news/who-warns-of-increasing-antibioticresistant-gonorrhea Antibiotic resistance is making gonorrhea increasingly harder to treat, the World Health Organization (WHO) warned in a recently published report.&nbsp; Mon, 10 Jul 17 19:52:13 +0000 Sugar Consumption During Pregnancy May Cause Allergies and Allergic Asthma in Children http://www.pharmacytimes.com/news/sugar-consumption-during-pregnancy-may-cause-allergies-and-allergic-asthma-in-children- http://www.pharmacytimes.com/news/sugar-consumption-during-pregnancy-may-cause-allergies-and-allergic-asthma-in-children- Researchers at the University of Bristol in the United Kingdom have published a study in <em>European Respiratory Journal</em> that analyzed sugar intake during pregnancy and the relationship to allergies and asthma in children. Fri, 07 Jul 17 19:00:21 +0000 Older Americans Don't Seek Help From Health Professionals for Drug Costs http://www.pharmacytimes.com/news/older-americans-dont-seek-help-from-health-professionals-for-drug-costs http://www.pharmacytimes.com/news/older-americans-dont-seek-help-from-health-professionals-for-drug-costs The results of the University of Michigan National Poll on Healthy Aging show that many Americans older than 50 take two or more prescription medications that take a toll on their finances. Fri, 07 Jul 17 16:00:32 +0000 Endo to Pull Opana From the Market Following FDA Request http://www.pharmacytimes.com/product-news/endo-to-pull-opana-from-the-market-following-fda-request http://www.pharmacytimes.com/product-news/endo-to-pull-opana-from-the-market-following-fda-request Endo International has announced its plan to withdraw Opana ER (oxymorphone hydrochloride extended release) from the market. Thu, 06 Jul 17 19:11:01 +0000 FDA Approves Drug for Active Psoriatic Arthritis http://www.pharmacytimes.com/product-news/fda-approves-drug-for-active-psoriatic-arthritis http://www.pharmacytimes.com/product-news/fda-approves-drug-for-active-psoriatic-arthritis The FDA has approved Bristol-Myers Squibb&rsquo;s abatacept (Orencia) in both intravenous (IV) and subcutaneous (SC) injections forms for the treatment of active Psoriatic Arthritis (PsA) in adults. The approval is the third autoimmune disease indication for Orencia.&nbsp;<br /> &nbsp; Thu, 06 Jul 17 17:57:02 +0000 FDA Orders Drug Compounding Company to Halt Operations http://www.pharmacytimes.com/news/fda-orders-drug-compounding-company-to-halt-operations http://www.pharmacytimes.com/news/fda-orders-drug-compounding-company-to-halt-operations FDA officials said that U.S. District Judge William H. Steele has entered a consent decree of permanent injunction against compounder Medistat RX, LLC, prohibiting the company from manufacturing or distributing products until it complies with appropriate regulations. Thu, 06 Jul 17 16:58:25 +0000 CDC Releases 40th Annual Health Report http://www.pharmacytimes.com/news/cdc-releases-40th-annual-health-report http://www.pharmacytimes.com/news/cdc-releases-40th-annual-health-report The CDC recently released its 40<sup>th</sup> annual report on the overall health and well-being of the United States for 2016. Fri, 30 Jun 17 16:55:50 +0000 FDA Attempting to Boost Generic Competition http://www.pharmacytimes.com/news/fda-attempting-to-boost-generic-competition http://www.pharmacytimes.com/news/fda-attempting-to-boost-generic-competition Part of the FDA&#39;s actions focuses on expediting review of generic applications.&nbsp; Wed, 28 Jun 17 16:44:56 +0000 CDC Report Focuses on Lyme Disease Treatments http://www.pharmacytimes.com/news/cdc-report-focuses-on-lyme-disease-treatments http://www.pharmacytimes.com/news/cdc-report-focuses-on-lyme-disease-treatments Summer has begun, and people must be more cautious of their surroundings when going outdoors.&nbsp; Wed, 28 Jun 17 12:00:00 +0000 Physician Charged in Pill Mill Operation http://www.pharmacytimes.com/news/physician-charged-in-pill-mill-operation http://www.pharmacytimes.com/news/physician-charged-in-pill-mill-operation A Staten Island physician was recently charged for his involvement in an oxycodone distribution conspiracy that yielded the diversion of millions of dollars&rsquo; worth of pain medication.&nbsp;<br /> &nbsp; Tue, 27 Jun 17 12:00:00 +0000 Venous Thromboembolism Prophylaxis Gets FDA Approval http://www.pharmacytimes.com/news/venous-thromboembolism-prophylaxis-gets-fda-approval http://www.pharmacytimes.com/news/venous-thromboembolism-prophylaxis-gets-fda-approval Bevyxxa has been approved based on data from Portola&#39;s phase 3 APEX Study.&nbsp; Fri, 23 Jun 17 18:25:02 +0000 Blood Cancer Treatment Gets FDA Nod http://www.pharmacytimes.com/product-news/blood-cancer-treatment-gets-fda-nod http://www.pharmacytimes.com/product-news/blood-cancer-treatment-gets-fda-nod The approval is based on multiple clinical trials, and provides patients with a subcutaneous option for rituximab that shortens the treatment time to 5 to 7 minutes compared with intravenous infusion. Fri, 23 Jun 17 01:23:34 +0000 FDA Approves C1 Esterase Inhibitor to Treat Genetic Disease http://www.pharmacytimes.com/news/fda-approves-c1-esterase-inhibitor-to-treat-genetic-disease http://www.pharmacytimes.com/news/fda-approves-c1-esterase-inhibitor-to-treat-genetic-disease Thu, 22 Jun 17 22:50:18 +0000 EMDAC Panel: Liraglutide Linked with Reduced CVD Risk in T2DM Patients http://www.pharmacytimes.com/product-news/emdac-panel-liraglutide-linked-with-reduced-cvd-risk-in-t2dm-patients- http://www.pharmacytimes.com/product-news/emdac-panel-liraglutide-linked-with-reduced-cvd-risk-in-t2dm-patients- The discussions at the Advisory Committee meeting were based on data from the LEADER trial.&nbsp; Wed, 21 Jun 17 14:58:49 +0000 ADHD Drug Gets FDA Nod http://www.pharmacytimes.com/news/adhd-drug-gets-fda-nod http://www.pharmacytimes.com/news/adhd-drug-gets-fda-nod Mydayis is not for use in children 12 years and younger. Wed, 21 Jun 17 07:55:24 +0000